Harvey R - Search Results

1

Passage of influenza A/H3N2 viruses in human airway cells removes artefactual variants associated with neuraminidase-mediated binding.

Brown JC, Barclay WS, Galiano M, Harvey R. Brown JC, et al. Among authors: harvey r. J Gen Virol. 2020 May;101(5):456-466. doi: 10.1099/jgv.0.001348. Epub 2019 Nov 6. J Gen Virol. 2020. PMID: 31702542 Free PMC article.

2

Isolation and characterization of a transfectant influenza B virus altered in RNA segment 6.

Rowley KV, Harvey R, Barclay WS. Rowley KV, et al. Among authors: harvey r. J Gen Virol. 1999 Sep;80 ( Pt 9):2353-2359. doi: 10.1099/0022-1317-80-9-2353. J Gen Virol. 1999. PMID: 10501487

3

Restrictions to the adaptation of influenza a virus h5 hemagglutinin to the human host.

Harvey R, Martin AC, Zambon M, Barclay WS. Harvey R, et al. J Virol. 2004 Jan;78(1):502-7. doi: 10.1128/jvi.78.1.502-507.2004. J Virol. 2004. PMID: 14671130 Free PMC article.

4

A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria.

Griffin SDC, Harvey R, Clarke DS, Barclay WS, Harris M, Rowlands DJ. Griffin SDC, et al. Among authors: harvey r. J Gen Virol. 2004 Feb;85(Pt 2):451-461. doi: 10.1099/vir.0.19634-0. J Gen Virol. 2004. PMID: 14769903

5

Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1).

Harvey R, Wheeler JX, Wallis CL, Robertson JS, Engelhardt OG. Harvey R, et al. Vaccine. 2008 Dec 2;26(51):6550-4. doi: 10.1016/j.vaccine.2008.09.050. Vaccine. 2008. PMID: 18840494

6

Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules.

Harvey R, Nicolson C, Johnson RE, Guilfoyle KA, Major DL, Robertson JS, Engelhardt OG. Harvey R, et al. Vaccine. 2010 Nov 23;28(50):8008-14. doi: 10.1016/j.vaccine.2010.09.006. Epub 2010 Oct 8. Vaccine. 2010. PMID: 20934460

7

Improved antigen yield in pandemic H1N1 (2009) candidate vaccine viruses with chimeric hemagglutinin molecules.

Harvey R, Guilfoyle KA, Roseby S, Robertson JS, Engelhardt OG. Harvey R, et al. J Virol. 2011 Jun;85(12):6086-90. doi: 10.1128/JVI.00096-11. Epub 2011 Apr 13. J Virol. 2011. PMID: 21490098 Free PMC article.

8

Permissible variation in the 3' non-coding region of the haemagglutinin genome segment of the H5N1 candidate influenza vaccine virus NIBRG-14 [corrected].

Johnson RE, Hamill M, Harvey R, Nicolson C, Robertson JS, Engelhardt OG. Johnson RE, et al. Among authors: harvey r. PLoS One. 2012;7(5):e36241. doi: 10.1371/journal.pone.0036241. Epub 2012 May 11. PLoS One. 2012. PMID: 22606247 Free PMC article.

9

A promoter mutation in the haemagglutinin segment of influenza A virus generates an effective candidate live attenuated vaccine.

Harvey R, Johnson RE, MacLellan-Gibson K, Robertson JS, Engelhardt OG. Harvey R, et al. Influenza Other Respir Viruses. 2014 Nov;8(6):605-12. doi: 10.1111/irv.12274. Epub 2014 Aug 2. Influenza Other Respir Viruses. 2014. PMID: 25087607 Free PMC article.

10

The Ability of a Non-Egg Adapted (Cell-Like) A(H1N1)pdm09 Virus to Egg-Adapt at HA Loci Other than 222 and 223 and Its Effect on the Yield of Viral Protein.

Nicolson C, Harvey R, Engelhardt OG, Robertson JS. Nicolson C, et al. Among authors: harvey r. PLoS One. 2016 Nov 18;11(11):e0166761. doi: 10.1371/journal.pone.0166761. eCollection 2016. PLoS One. 2016. PMID: 27861557 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,968 results

Search Page

Filters